Taokaenoi Food & Marketing Public Company Limited (“Company”) would like clarify the revenue from sales and net profit in the consolidated financial statements for the year ended December 31, 2018 as follow
Taokaenoi Food & Marketing Public Company Limited (“Company”) would like clarify the revenue from sales and net profit in the consolidated financial statements for the nine-month period ended September 30
Taokaenoi Food & Marketing Public Company Limited (“Company”) would like clarify the revenue from sales and net profit in the consolidated financial statements for the year ended December 31, 2019 as follow
Taokaenoi Food & Marketing Public Company Limited (“Company”) would like to clarify the sales revenue and net profit in the consolidated financial statements for the six-month period ended June 30, 2017 as
Taokaenoi Food & Marketing Public Company Limited (“Company”) would like clarify the revenue from sales and net profit in the consolidated financial statements for the six-month period ended June 30, 2019 as
Taokaenoi Food & Marketing Public Company Limited (the “Company”) would like clarify the revenue from sales and net profit in the consolidated financial statements for the six-month period ended June 30, 2020
-month period ended 30 June 2020 and 2019, consolidated financial statement has net profit of Baht 4 million and Baht 48 million, respectively. This was resulted from the effect of the outbreak of
support the growth of the Company group in the future including Fintech in Thailand. In the first quarter of 2019, the Company had operating results according to the consolidated financial statements, with
support the growth of the Company group in the future including Fintech in Thailand. In the first quarter of 2019, the Company had operating results according to the consolidated financial statements, with
498 mn with immaterial impact to CPN’s consolidated net profit. The difference versus GLAND’s reported statement of comprehensive income is down to the difference in accounting treatment of investment